Search Grant Opportunities

Sexually Transmitted Infections (STI) Surveillance Network (SSuN) Cycle 5

ID: CDC-RFA-PS-24-0082 • Type: Posted

Description

Posted: Feb. 8, 2024, 12:00 a.m. EST
CDC announces availability of fiscal year 2024 funding for a cooperative agreement for Cycle 5 of the STI Surveillance Network (SSuN). Continuing resurgence of sexually transmitted infections (STIs), along with the imperative to implement syndemic approaches to disease surveillance addressing related epidemics such as Human Immunodeficiency Virus (HIV) and mpox (Orthopox virus previously referred to as monkeypox) inform this competitive Notice of Funding Opportunity (NOFO) which will support integrated sentinel and enhanced surveillance at the local, state, and national level. Emergent issues of concern such as mpox and antimicrobial resistant STIs add urgency to the maintenance of robust syndemic surveillance at the community level and in sexual health clinical settings. The purpose of this NOFO is to support sentinel and enhanced surveillance for STIs providing complete demographics, behavioral risk, clinical and preventive services data missing in routine reporting. Sentinel clinic surveillance, enhanced investigations of reported cases, and special projects funded by this NOFO will provide epidemiologic and preventive services information filling gaps in knowledge regarding STI prevention priorities. These data improve the ability of public health agencies to address STI/HIV health equity outcomes and syndemic interactions in populations with shared risks.This NOFO supports two core strategies for (A) sentinel surveillance in STI/sexual health clinical facilities, and (B) enhanced case-based surveillance in community settings and one supplemental strategy (Strategy C) for special surveillance projects of national or local interest. Both core strategies integrate a syndemic approach to monitoring STIs, HIV, behavioral data, and on preventive services accessed by all persons presenting for care in sexual health settings, and persons diagnosed and reported with selected STIs from all provider settings in defined geographic areas. The goal of this NOFO is to monitor and report trends in patient characteristics, screening, and diagnoses to identify opportunities and gaps across the STI/HIV prevention and surveillance continuum. Protocols are designed to address critical information gaps in routine national case reporting and incorporate local flexibility to respond to emergent health issues by supporting a network of geographically diverse health departments and an expanded network of clinical partners. These efforts complement existing state, local and national surveillance strategies and enhance the capacity of health departments to collect high-quality, timely data to inform disease prevention and control activities.
Posted: Feb. 8, 2024, 12:00 a.m. EST
Posted: Feb. 8, 2024, 12:00 a.m. EST
Posted: Feb. 8, 2024, 12:00 a.m. EST
Posted: Sept. 7, 2023, 12:00 a.m. EDT
Posted: Sept. 7, 2023, 12:00 a.m. EDT
Posted: Sept. 7, 2023, 12:00 a.m. EDT
Posted: Sept. 7, 2023, 12:00 a.m. EDT
Posted: Sept. 7, 2023, 12:00 a.m. EDT
Background
CDC announces availability of fiscal year 2024 funding for a cooperative agreement for Cycle 5 of the STI Surveillance Network (SSuN). Continuing resurgence of sexually transmitted infections (STIs), along with the imperative to implement syndemic approaches to disease surveillance addressing related epidemics such as Human Immunodeficiency Virus (HIV) and mpox (Orthopox virus previously referred to as monkeypox) inform this competitive Notice of Funding Opportunity (NOFO) which will support integrated sentinel and enhanced surveillance at the local, state, and national level. The purpose of this NOFO is to support sentinel and enhanced surveillance for STIs providing complete demographics, behavioral risk, clinical and preventive services data missing in routine reporting. This NOFO supports two core strategies for (A) sentinel surveillance in STI/sexual health clinical facilities, and (B) enhanced case-based surveillance in community settings and one supplemental strategy (Strategy C) for special surveillance projects of national or local interest. Both core strategies integrate a syndemic approach to monitoring STIs, HIV, behavioral data, and on preventive services accessed by all persons presenting for care in sexual health settings, and persons diagnosed and reported with selected STIs from all provider settings in defined geographic areas.

Grant Details
In 2022, more than 2.5 million cases of syphilis, gonorrhea and chlamydia were reported to CDC representing an increase of 1.9% since 2018. Sexually transmitted infections (STIs) can have long-term health consequences, especially regarding reproductive health. Rates of congenital syphilis continue to surge with over 3,700 cases reported in 2022, an increase of over 900% in the last decade. STIs represent a significant economic drain on the U.S. healthcare system, with annual costs estimated to be nearly $16 billion in 2018. Persons at risk for or diagnosed with bacterial STIs are at increased risk for acquisition or transmission of HIV. Recent emergence and global spread of mpox through overlapping global sexual networks highlight the importance of improving the surveillance infrastructure for monitoring population-level incidence of STIs. Significant inequities in the burden of STIs in the U.S., including differential access to and utilization of preventive services by racial, ethnic and gender/sexual minority populations have also been documented.

Eligibility Requirements
Open Competition

Period of Performance
5 year(s)

Grant Value
$40,000,000 Up to $40,000,000; contingent on the availability of federal funding.

Overview

Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 2/8/24 National Center for HIV, Viral Hepatitis, STD, and TB Prevention posted grant opportunity CDC-RFA-PS-24-0082 for Sexually Transmitted Infections (STI) Surveillance Network (SSuN) Cycle 5 with funding of $40.0 million. The grant will be issued under grant program 93.977 Sexually Transmitted Diseases (STD) Prevention and Control Grants. It is expected that 30 total grants will be made.

Timing

Posted Date
Feb. 8, 2024, 12:00 a.m. EST
Closing Date
May 15, 2024, 12:00 a.m. EDT Past Due
Closing Date Explanation
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Last Updated
March 27, 2024, 11:20 a.m. EDT
Version
4
Archive Date
June 14, 2024

Eligibility

Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Info
Applicants must apply for at least one of the two core strategies (A or B or both) of this NOFO. Applicants proposing any Strategy C activity but not proposing either or both core strategies (Strategy A and/or Strategy B) will be considered non-responsive and will not receive further review.Applicants must provide documentary evidence (e.g., letter of support, MOA or MOU) from the designated Overall Responsible Party (ORP) for HIV surveillance in their jurisdiction. A MOU or MOA is preferred but LOSs are acceptable if there isn’t sufficient time to execute a formal MOU/MOA. Documentary evidence should clearly demonstrate the collaboration and the ability to match, based on name, their STI clinic patient census and/or reported cases of gonorrhea and syphilis (all stages) with the jurisdiction’s HIV case registry. Access to the jurisdiction’s HIV case registry (eHARS or similar proxy) is critical to successfully implement the required program strategies, either through the applicant agency’s internal systems or through agreements with relevant health department entities. This requirement applies to Strategy A and/or Strategy B applications. Name this signed letter “HIV_ORP_MOA” and upload as an attachment with the application package at www.grants.gov. Applicants failing to provide documentary evidence from the jurisdiction's ORP for HIV surveillance will be considered non-responsive and will not receive further review. Please note: Sections 317 and 318 of the Public Health Service Act authorize funding to States, political subdivisions of States, and any other public and nonprofit private entities, but do not authorize awards to for-profit entities.

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$40,000,000
Estimated Number of Grants
30

Contacts

Contact
Centers for Disease Control - NCHHSTP
Contact Email
Contact Phone
(770) 488-2756

Documents

Posted documents for CDC-RFA-PS-24-0082

Grant Awards

Grants awarded through CDC-RFA-PS-24-0082

Incumbent or Similar Grants

Grants similar to CDC-RFA-PS-24-0082

Similar Active Opportunities

Open grant opportunities similar to CDC-RFA-PS-24-0082